Greatview Aseptic Packaging (468) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
11 Sep, 2026Executive summary
Revenue for the first half of 2026 declined 14.5% year-over-year to RMB861.0 million, with net profit plunging 91.7% to RMB6.9 million, mainly due to lower gross margin, reduced international business, and higher administrative expenses.
The company sold approximately 5.81 billion packs, down 7.6% from the prior year, with the PRC segment showing resilience while international sales dropped sharply.
Strategic focus included digital transformation, green packaging initiatives, and operational efficiency improvements, with notable recognition for product innovation and sustainability.
PRC segment revenue fell 1.8% mainly from lower average sales prices and reduced filling machine revenue, while international segment revenue dropped 52.3% due to lower sales volume and prices.
Gross margin decreased to 14.3% from 16.1% year-over-year, and net profit margin dropped to 0.8% from 8.2%.
Financial highlights
Revenue decreased to RMB861.0 million from RMB1,006.7 million year-over-year.
Gross profit fell 24.2% to RMB122.8 million; other income decreased 45.8% to RMB14.8 million.
Administrative expenses rose 30% to RMB102.6 million, while selling and distribution expenses decreased 24.8% to RMB24.6 million.
Cash and cash equivalents declined to RMB211.3 million from RMB461.7 million at year-end 2025.
No interim dividend was declared.
Outlook and guidance
Plans to deepen digital transformation, strengthen supply chain resilience, and expand both PRC and international markets.
Focus on innovation, sustainability, and operational excellence to build core competitiveness.
Continued attention to cost control, product quality, and leveraging AI and IoT technologies.
Strategic priorities include expanding PRC market share, steady international growth, technological innovation, and enhanced ESG practices.
Latest events from Greatview Aseptic Packaging
- Sharp profit decline, restructuring, and internal control issues drive major remedial actions.468
H2 2025 - Net profit fell 32.4% on lower margins; trading remains suspended after major shareholding change.468
H1 2025 - Revenue and profit plunged amid governance overhaul, investigations, and trading suspension.468
H2 2024 - Net profit rose 17.7% despite a 13.9% revenue drop, amid restructuring and takeover activity.468
H1 2024